Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety. Credit...Blake Cale Supported by By Walt Bogdanich Carson Kessler ...
Between 2022-2025, Joel Lexchin received payments for writing a brief for a legal firm on the role of promotion in generating prescriptions for opioids, for being on a panel about pharmacare and for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results